Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001230

Director bought 26,172 shares at an average $5.10 ($133,392)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-13 Purchase : show line 1 in the form +19,953 $5.13 $102,359 4,969,413 I
2022-01-14 Purchase : show line 2 in the form +6,219 $4.99 $31,033 4,975,632 I
Open-market purchases · 26,172 sh · avg $5.10 · $133,392
Loading xslF345X03/doc1.xml…